Overexpression of tumor necrosis factor-α produces an increase in lung volumes and pulmonary hypertension

被引:170
作者
Fujita, M
Shannon, JM
Irvin, CG
Fagan, KA
Cool, C
Augustin, A
Mason, RJ
机构
[1] Natl Jewish Med & Res Ctr, Dept Med, Denver, CO 80206 USA
[2] Univ Colorado, Hlth Sci Ctr, Cardiovasc Pulm Res Lab, Denver, CO 80262 USA
关键词
emphysema; pulmonary fibrosis; pulmonary hypertension;
D O I
10.1152/ajplung.2001.280.1.L39
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Tumor necrosis factor (TNF)-alpha is a key proinflammatory cytokine that is thought to be important in the development of pulmonary fibrosis, whereas its role in pulmonary emphysema has not been as thoroughly documented. In the present study, TNF-alpha was overexpressed in alveolar type II cells under the control of the human surfactant protein C promoter. In this report, we further characterized the pulmonary abnormalities and provided a physiological assessment of these mice. Histopathology of the lungs revealed chronic inflammation, severe alveolar air space enlargement and septal destruction, and bronchiolitis. However, pulmonary fibrosis was very limited and only seen in the subpleural, peribronchiolar, and perivascular regions. Physiological assessment showed an increase in lung volumes and a decrease in elastic recoil characteristic of emphysema; there was no evidence of restrictive lung disease characteristic of pulmonary fibrosis. In addition, the mice raised in ambient conditions in Denver developed pulmonary hypertension. Gelatinase activity was increased in the lavage fluid from these lungs. These results suggest that in these mice TNF-alpha contributed to the development of pulmonary emphysema through chronic lung inflammation and activation of the elastolytic enzymes but by itself was unable to produce significant pulmonary fibrosis.
引用
收藏
页码:L39 / L49
页数:11
相关论文
共 48 条
  • [31] Different cytokine patterns in bronchial biopsies in asthma and chronic bronchitis
    Mueller, R
    Chanez, P
    Campbell, AM
    Bousquet, J
    Heusser, C
    Bullock, GR
    [J]. RESPIRATORY MEDICINE, 1996, 90 (02) : 79 - 85
  • [32] COMPARTMENTALIZATION OF INTRAALVEOLAR AND SYSTEMIC LIPOPOLYSACCHARIDE-INDUCED TUMOR NECROSIS FACTOR AND THE PULMONARY INFLAMMATORY RESPONSE
    NELSON, S
    BAGBY, GJ
    BAINTON, BG
    WILSON, LA
    THOMPSON, JJ
    SUMMER, WR
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (02) : 189 - 194
  • [33] MATRIX METALLOPROTEASES AND LUNG-DISEASE
    OCONNOR, CM
    FITZGERALD, MX
    [J]. THORAX, 1994, 49 (06) : 602 - 609
  • [34] Ohnishi K, 1998, LAB INVEST, V78, P1077
  • [35] TREATMENT BY HUMAN RECOMBINANT SOLUBLE TNF RECEPTOR OF PULMONARY FIBROSIS INDUCED BY BLEOMYCIN OR SILICA IN MICE
    PIGUET, PF
    VESIN, C
    [J]. EUROPEAN RESPIRATORY JOURNAL, 1994, 7 (03) : 515 - 518
  • [36] TUMOR NECROSIS FACTOR CACHECTIN PLAYS A KEY ROLE IN BLEOMYCIN-INDUCED PNEUMONOPATHY AND FIBROSIS
    PIGUET, PF
    COLLART, MA
    GRAU, GE
    KAPANCI, Y
    VASSALLI, P
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (03) : 655 - 663
  • [37] REQUIREMENT OF TUMOR-NECROSIS-FACTOR FOR DEVELOPMENT OF SILICA-INDUCED PULMONARY FIBROSIS
    PIGUET, PF
    COLLART, MA
    GRAU, GE
    SAPPINO, AP
    VASSALLI, P
    [J]. NATURE, 1990, 344 (6263) : 245 - 247
  • [38] PIGUET PF, 1993, AM J PATHOL, V143, P651
  • [39] SCHOENHAUT DS, 1992, J IMMUNOL, V148, P3433
  • [40] SENIOR RM, 1991, J BIOL CHEM, V266, P7870